Bicycle Therapeutics plc (BCYC)

NASDAQ: BCYC · Real-Time Price · USD

3.870

+0.010 (0.26%)

At close: Aug 3, 2026, 4:00 PM EDT

3.875

+0.005 (0.13%)

After-hours: Aug 3, 2026, 7:34 PM EDT

Bicycle Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	510.05	628.11	879.52	526.42	339.15	438.68
Cash & Short-Term Investments	510.05	628.11	879.52	526.42	339.15	438.68
Cash Growth	-29.30%	-28.59%	67.07%	55.22%	-22.69%	222.58%
Accounts Receivable	-	-	-	-	2.05	1
Other Receivables	47.42	35.59	35.65	24.04	19.16	10.91
Total Trade Receivables	47.42	35.59	35.65	24.04	21.21	11.91
Other Current Assets	17.77	19.18	13.43	11.41	9.02	7.97
Total Current Assets	575.24	682.89	928.61	561.87	369.38	458.56
Net Property, Plant & Equipment	18.67	21.91	17.19	27.68	32.77	17.79
Other Long-Term Assets	12.67	12.81	11.07	5.79	8.46	3.45
Total Assets	606.58	717.6	956.87	595.34	410.61	479.79
Accounts Payable	5.66	9.67	15.79	13.05	6.47	2.72
Accrued Expenses	39.09	44.35	41.25	31.51	26.45	14.24
Unearned Revenue	2.88	2.96	10.19	24.98	20.42	19.27
Total Current Liabilities	47.64	56.98	67.23	69.54	53.34	36.24
Long-Term Debt	-	-	-	30.7	30.32	29.87
Long-Term Leases	13.68	14.1	3.99	9.38	10.89	12.08
Other Long-Term Liabilities	35.01	36.54	92.59	114.8	45.28	55.35
Total Long-Term Liabilities	48.69	50.64	96.58	154.88	86.48	97.3
Total Liabilities	96.32	107.62	163.81	224.41	139.83	133.54
Common Stock	0.9	0.89	0.89	0.55	0.39	0.38
Additional Paid-in Capital	1,526	1,512	1,473	883.45	601.11	567.64
Accumulated Other Comprehensive Income	-5.42	-3.51	0.12	-1.3	0.39	-3.39
Retained Earnings	-1,011	-899.75	-680.79	-511.76	-331.1	-218.38
Shareholders' Equity	510.26	609.98	793.06	370.93	270.78	346.25
Total Liabilities & Equity	606.58	717.6	956.87	595.34	410.61	479.79
Total Debt	13.68	14.1	3.99	40.08	41.2	41.95
Net Cash (Debt)	496.37	614.01	875.53	486.34	297.95	396.73
Net Cash Growth	-31.03%	-29.87%	80.02%	63.23%	-24.90%	227.71%
Net Cash Per Share	7.14	8.86	15.04	13.66	10.04	15.83
Book Value	510.26	609.98	793.06	370.93	270.78	346.25
Book Value Per Share	7.34	8.80	13.62	10.42	9.13	13.82
Tangible Book Value	510.26	609.98	793.06	370.93	270.78	346.25
Tangible Book Value Per Share	7.34	8.80	13.62	10.42	9.13	13.82

SEC Filings: 10-K · 10-Q